map @Bio_Scout

I scout for hidden clues that offer promise or warning for a stock and post on twitter. Mostly biotech. Joined September 2012

Tweets

1K
Followers

350
Following

77
Likes

7K

map @Bio_Scout

17 hours ago

$CLSD @clearsidebio Clearside receives protected patent extension in Hong Kong on 9/5/25 for their SCS microinjector. ipd.gov.hk/hkipjournal/05…

0 0 0 55 0

$CLSD $RGNX @clearsidebio @REGENXBIO Late Breaking Abstract for the AAO conference Oct. 17-20th Suprachoroidal Surabgene Lomparvovec (Sura-vec, ABBV-RGX-314): First Time 2-Year Results in Non-Proliferative Diabetic Retinopathy Dr. Wykoff, MD, PhD aao.apprisor.org/apsSession.cfm…

0 0 1 309 0

map @Bio_Scout

2 weeks ago

$BCRX $CLSD @BioCrystPharma @clearsidebio Hey Biocryst, have you looked at the 4-week data on the PH1 Avoralstat trial? Any chance for an update cause it's likely going to be excellent!

0 0 1 258 0

map @Bio_Scout

3 weeks ago

$OCUL $CLSD $EYPT TKIs only need 6 months benefits as Drs. want to see patients in 6 months or less per Dr. Peter Kaiser: Start at 21:45 So does the 9-12 months even matter? All TKIs can get 6 months, so safety and efficacy win...CLSD get in the race! youtube.com/watch?v=URyNFB…

2 2 4 4K 1

map @Bio_Scout

3 weeks ago

$RGNX @REGENXBIO $ABBV $CLSD @clearsidebio Look for Late Breaking Abstracts at AAO 2025 (10/18-20) for data results on ABBV-RGX-314 for Diabetic Retinopathy via the suprachoroidal ALTITUDE study using Clearside's microinjector: aao.apprisor.org/apsSearchEs.cfm

0 0 2 419 0

map @Bio_Scout

3 weeks ago

$CLSD Kriya Therapeutics just received $330 million of undisclosed purpose funds last Fri. They are a non-publicly traded Co. that focuses on the suprachoroidal space...REVERSE MERGER possibility with Clearside @clearsidebio stocktwits.com/maphere/messag…

0 0 2 420 0

map @Bio_Scout

4 weeks ago

$CLSD Flagship new patent that includes Clearside ____________ GENE THERAPY FOR TREATING AN OCULAR DISEASE The suprachoroidal drug delivery devices that can be used to deposit the recombinant AAV ...SCS devices manufactured by Clearside® Biomedical patentscope.wipo.int/search/en/deta…

0 0 2 349 0

map @Bio_Scout

a month ago

$RGNX $OCUL $EYPT $CLSD ASRS survey shows Retina Specialists are most excited about gene therapy for future treatment of Wet AMD...only 18% for TKIs. Don't shoot the messenger this is what the community of Retina Specialists are saying. asrs.org/asrs-community…

4 0 2 1K 2

Download Image

map @Bio_Scout

a month ago

$BCRX @BioCrystPharma $CLSD @clearsidebio Biocryst doses first patients in new PH1 DME trial with BCX4161 into the suprachoroidal space using Clearside Biomedical's microinjector. Results in 4Q25. ophthalmologytimes.com/view/asrs-2025…

0 0 0 310 0

map @Bio_Scout

a month ago

$CLSD @clearsidebio @OISRETINA @ASRS2025 Lots of activity in Longbeach for the combo conferences of ASRS and OIS Retina Summit. A wink and a nod can go a long way...maybe:-) Biocryst with DME presentation using SCS. stocktwits.com/maphere/messag…

0 0 0 112 0

map @Bio_Scout

a month ago

$CLSD $RGNX $ABBV @clearsidebio @REGENXBIO The PH2 DR SCS trial changed status today to "Active, Not Recruiting"... Let's hear an update this week from ABBVIE on the PH3 pivotal. clinicaltrials.gov/study/NCT04567…

0 0 1 283 0

map @Bio_Scout

2 months ago

$CLSD @RGNx @clearsidebio Discussion at Hawaiian Eye Jan. 2026: "Why We Need a Robust Suprachoroidal Pipeline" Kuldev Singh, MD, MPH Professor of Ophthalmology Stanford University healio.com/meeting/hawaii…

0 0 0 70 0

map @Bio_Scout

2 months ago

$CLSD @clearsidebio @NIH NIH offers $3,600,000 to UC Davis for gene therapy research using Clearside's patented microinjector. The govt. is taking notice of suprachoroidal technology and the benefits it offers to deliver gene therapy to the eye. health.ucdavis.edu/news/headlines…

0 0 1 129 0

map @Bio_Scout

2 months ago

$ABBV @clsd @abbvie @REGENXBIO @clearsidebio Abbvie ER on the 31st. Clearside's strategic planning PR a few days ago paves the way for ABBV to update their PH3 DR trial using Clearside's microinjector and possible bolt-on to their ophthalmology programs.

0 1 2 313 0

map @Bio_Scout

2 months ago

$CLSD @clearsidebio Confirmed by IR, NEW DATA on DryAMD coming Dec. 10th. Clearside has a couple Aces up their sleeves.

map @Bio_Scout

2 months ago

$CLSD @clearsidebio Confirmed by IR, NEW DATA on DryAMD coming Dec. 10th. Clearside has a couple Aces up their sleeves.

1 0 0 779 0

Download Image

0 1 3 563 0

map @Bio_Scout

2 months ago

$BLCO @BauschLomb $CLSD @clearsidebio Hey Bausch, where's the PR for approval of Xipere in Canada that happened on the 14th, this is a material event especially for Clearside. health-products.canada.ca/dpd-bdpp/dispa…

0 0 0 198 0

map @Bio_Scout

2 months ago

$CLSD $RGNX @REGENXBIO $ABBV Hey Regenxbio, when will you start the PH1 for Dry AMD? Start at 25:15. May 1st interview. globalgenes.org/raredaily/an-e…

0 0 1 317 0

map @Bio_Scout

2 months ago

$CLSD $RGNX $ABBV @clearsidebio Regenxbio / ABBVIE are pressured to update the PH3 DR trial plans with coming ERs. This trial includes Clearside's microinjector. DR is a multi-billion opportunity, easier to BO CLSD than worry about patents and changing a device for SCS no FDA.